The Dispensatory of the United States of America

PEDIATRICS ◽  
1948 ◽  
Vol 1 (6) ◽  
pp. 846-846
Keyword(s):  
United States ◽  
Drug Administration ◽  
United States Of America ◽  
Editorial Policy ◽  
The United States ◽  
Trade Mark ◽  
British Pharmacopoeia ◽  
Therapeutic Uses ◽  
Trade Name ◽  
New Feature

This edition is based on the U. S. P. XIII, N.F. VIII, N.N.R., 1947, and the British Pharmacopoeia, 1932, and its addenda. The significant change in editorial policy is the enlargement of that portion of each monograph devoted to a discussion of therapeutic uses and dosage of drugs, and an increased emphasis placed upon precautions to be observed during drug administration. Another new feature is the inclusion of the name of the manufacturer or distributor whose trade name or trade mark of the drug being discussed. It contains complete medical and pharmaceutical information of every drug used in medicine.

scholarly journals Protective Immunity against COVID-19

2021 ◽  
Author(s):  
Anjali Priyadarshini ◽  
Archana Gupta ◽  
Manoj Kumar Yadav ◽  
Arpana Vibhuti ◽  
Ramendra Pati Pandey ◽  
...  
Keyword(s):  
United States ◽  
Immune Responses ◽  
Drug Administration ◽  
United States Of America ◽  
Protective Immunity ◽  
The United States ◽  
The Novel ◽  
Infectious Agents ◽  
Novel Coronavirus ◽  
Target Effects

Tuberculosis and Covid-19 infection measure two quite different diseases- TB is caused by a sort of bacterium whereas Covid-19 is caused by a virus. However, the BCG immunizing agent would possibly facilitate individuals build immune responses to things aside from TB, inflicting "off-target effects," In different words, in run format, individuals started learning positive in obtaining the immunizing agent that had nothing to try and do with TB, several studies showed however the BCG immunizing agent affects individuals with kind one although the precise mechanism for these off-target effects of the BCG immunizing agent is not clear, it's believed that the immunizing agent will cause a nonspecific boost of the reaction. There is presently no immunizing agent or treatments approved by the United States of America Food and Drug Administration for the novel coronavirus. BCG is usually innocuous with the most facet impact the event of inflammation at the positioning of injection. Supported by these observations BCG so emerges as a possible candidate for the development of innate and adjustive reactions which can be non-specifically taking care of mycobacterium and different infectious agents against that vaccine remains not on the market.

United States Dispensatory. Twenty-first Edition, Thoroughly Revised, Largely Rewritten, and based upon the Tenth Revision of the United States Pharmacopœia, National Formulary Fifth Edition, and the British Pharmacopœia 1914. By Horatio C. Wood, Jr., M.D., Professor of Pharmacology and Therapeutics in the University of Pennsylvania, Professor of Materia Medica in the Philadelphia College of Pharmacy and Science, Member of the Committee of Revision of the Pharmacopœia of the United States of America; Charles H. LaWall, Ph.M., D.Sc., Phar.D., Professor of Theory and Practice of Pharmacy in the Philadelphia College of Pharmacy and Science, Member of the Committee of Revision of the Pharmacopœia of the United States of America; Heber W. Youngken, Ph.M., Ph.D., Professor of Botany, Pharmacognosy and Materia Medica in the Massachusetts College of Pharmacy, Member of the Committee of Revision of the Pharmacopœia of the United States of America; John F. Anderson, M.D., Member of the Committee of Revision of the Pharmacopœia of the United States of America; Ivor Griffith, Ph.M., Assistant Professor in Pharmacy in the Philadelphia College of Pharmacy and Science. Buckram, 7 by 10¼ inches; pages xxx, 1792. Philadelphia and London: J. B. Lippincott Company, 1926. Price $15.00; with Thub Index, $15.75

1927 ◽  
Vol 16 (2) ◽  
pp. 188
Keyword(s):  
United States ◽  
United States Of America ◽  
Assistant Professor ◽  
The United States ◽  
Theory And Practice ◽  
University Of Pennsylvania ◽  
United States Pharmacopoeia ◽  
British Pharmacopoeia ◽  
Materia Medica ◽  
The University

Tartrazine Revisited

1975 ◽  
Vol 9 (4) ◽  
pp. 198-203 ◽  
Author(s):  
Monte S. Cohon
Keyword(s):  
United States ◽  
Drug Administration ◽  
United States Of America ◽  
Food And Drug Administration ◽  
Clinical Manifestations ◽  
The United States ◽  
Allergic Reactions ◽  
Pharmaceutical Manufacturers

A compilation of tartrazine (FD and C No. 5) containing drugs from major pharmaceutical manufacturers in the United States of America appears. Characteristics of tartrazine, spectrum of its use, incidence of allergic reactions and relationship with other food and drug dyes are discussed, as are the clinical manifestations of such reactions. The importance of coercive tartrazine disclosure, as well as the disclosure of other excipients and additives by the Food and Drug Administration is emphasized.

scholarly journals Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database

2015 ◽  
Vol 25 (S2) ◽  
pp. 172-180 ◽  
Author(s):  
Kevin D. Hill ◽  
Heather T. Henderson ◽  
Christoph P. Hornik ◽  
Jennifer S. Li
Keyword(s):  
United States ◽  
Clinical Trials ◽  
Optimal Design ◽  
Drug Administration ◽  
United States Of America ◽  
Capital Investment ◽  
Food And Drug Administration ◽  
The United States ◽  
Pediatric Drug ◽  
The Impact

AbstractRecent regulatory initiatives in the United States of America and Europe have transformed the paediatric clinical trials landscape by significantly increasing capital investment and paediatric trial volume. The purpose of this manuscript was to review the impact of these initiatives on the paediatric cardiovascular trials landscape when compared with other paediatric sub-specialties. We also evaluate factors that may have contributed to the success or failure of recent major paediatric cardiovascular trials so as to inform the optimal design and conduct of future trials in the field.

Sign in / Sign up

Export Citation Format

Share Document